$AIMT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aimmune Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Aimmune Therapeutics, Inc.. Get notifications about new insider transactions in Aimmune Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 15 2020 | AIMT | Aimmune Therapeuti ... | Societe des Produits Nestle S. ... | 10% Owner | Buy | P | 34.50 | 10,681,704 | 368,518,788 | 23,408,817 | 12.7 M to 23.4 M (+83.93 %) |
Oct 15 2020 | AIMT | Aimmune Therapeuti ... | Societe des Produits Nestle S. ... | 10% Owner | Buy | P | 34.50 | 43,435,583 | 1,498,527,614 | 43,435,583 | 0 to 43.4 M |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Option Exercise | D | 23.81 | 67,500 | 1,607,175 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Option Exercise | D | 21.94 | 150,000 | 3,291,000 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Sell | D | 34.50 | 20,250 | 698,625 | 0 | 20.3 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Sell | U | 34.50 | 6,345 | 218,903 | 0 | 6.3 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | D | 23.81 | 67,500 | 1,607,175 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | D | 23.72 | 75,000 | 1,779,000 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | D | 34.07 | 75,000 | 2,555,250 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | D | 19.63 | 67,500 | 1,325,025 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | D | 12.95 | 22,361 | 289,575 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | D | 34.50 | 36,875 | 1,272,188 | 0 | 36.9 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | U | 34.50 | 47,450 | 1,637,025 | 0 | 47.5 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Option Exercise | D | 23.81 | 200,000 | 4,762,000 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Option Exercise | D | 23.72 | 210,000 | 4,981,200 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Option Exercise | D | 30.68 | 350,000 | 10,738,000 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Sell | D | 34.50 | 89,250 | 3,079,125 | 0 | 89.3 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Sell | U | 34.50 | 30,422 | 1,049,559 | 0 | 30.4 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | MCDADE MARK | Director | Option Exercise | D | 17.11 | 15,398 | 263,460 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | MCDADE MARK | Director | Option Exercise | D | 19.90 | 11,432 | 227,497 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | MCDADE MARK | Director | Option Exercise | D | 32.79 | 7,500 | 245,925 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | MCDADE MARK | Director | Option Exercise | D | 18.26 | 17,500 | 319,550 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | MCDADE MARK | Director | Option Exercise | D | 15.40 | 19,755 | 304,227 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | MCDADE MARK | Director | Option Exercise | D | 3.02 | 104,842 | 316,623 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | MCDADE MARK | Director | Sell | D | 34.50 | 7,840 | 270,480 | 0 | 7.8 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | MCDADE MARK | Director | Sell | U | 34.50 | 26,852 | 926,394 | 0 | 26.9 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Behar Gregory | Director | Option Exercise | D | 17.11 | 15,398 | 263,460 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Behar Gregory | Director | Option Exercise | D | 19.90 | 11,432 | 227,497 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Behar Gregory | Director | Option Exercise | D | 32.79 | 7,500 | 245,925 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Behar Gregory | Director | Option Exercise | D | 18.26 | 17,500 | 319,550 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Behar Gregory | Director | Option Exercise | D | 24.90 | 39,510 | 983,799 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Behar Gregory | Director | Sell | D | 34.50 | 7,840 | 270,480 | 0 | 7.8 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Behar Gregory | Director | Sell | J | 0.00 | 10,192 | 0 | 0 | 10.2 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | HAUMANN BRETT K | Director | Option Exercise | D | 17.11 | 25,453 | 435,501 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | HAUMANN BRETT K | Director | Sell | D | 34.50 | 13,313 | 459,299 | 0 | 13.3 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | HAUMANN BRETT K | Director | Sell | U | 34.50 | 6,250 | 215,625 | 0 | 6.3 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Seltzer Stacey Denenberg | Director | Option Exercise | D | 17.11 | 15,398 | 263,460 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Seltzer Stacey Denenberg | Director | Option Exercise | D | 19.90 | 11,432 | 227,497 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Seltzer Stacey Denenberg | Director | Option Exercise | D | 32.79 | 7,500 | 245,925 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Seltzer Stacey Denenberg | Director | Option Exercise | D | 18.26 | 17,500 | 319,550 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Seltzer Stacey Denenberg | Director | Option Exercise | D | 15.40 | 19,755 | 304,227 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Seltzer Stacey Denenberg | Director | Option Exercise | D | 6.29 | 52,421 | 329,728 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Seltzer Stacey Denenberg | Director | Sell | D | 34.50 | 7,840 | 270,480 | 0 | 7.8 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Seltzer Stacey Denenberg | Director | Sell | U | 34.50 | 10,221 | 352,625 | 0 | 10.2 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | D | 23.81 | 56,250 | 1,339,313 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | D | 23.72 | 78,750 | 1,867,950 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | D | 34.07 | 56,250 | 1,916,438 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | D | 19.44 | 264,800 | 5,147,712 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Sell | D | 34.50 | 23,905 | 824,723 | 0 | 23.9 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Sell | U | 34.50 | 27,805 | 959,273 | 0 | 27.8 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Iwicki Mark T | Director | Option Exercise | D | 17.11 | 15,398 | 263,460 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Iwicki Mark T | Director | Option Exercise | D | 19.90 | 11,432 | 227,497 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Iwicki Mark T | Director | Option Exercise | D | 32.79 | 7,500 | 245,925 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Iwicki Mark T | Director | Option Exercise | D | 18.26 | 17,500 | 319,550 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Iwicki Mark T | Director | Option Exercise | D | 15.40 | 19,755 | 304,227 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Iwicki Mark T | Director | Option Exercise | D | 6.29 | 87,368 | 549,545 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Iwicki Mark T | Director | Option Exercise | D | 3.02 | 52,421 | 158,311 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Iwicki Mark T | Director | Sell | D | 34.50 | 7,840 | 270,480 | 0 | 7.8 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | Iwicki Mark T | Director | Sell | U | 34.50 | 39,567 | 1,365,062 | 0 | 39.6 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | D | 17.11 | 15,398 | 263,460 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | D | 19.90 | 11,432 | 227,497 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | D | 32.79 | 7,500 | 245,925 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | D | 18.26 | 17,500 | 319,550 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | D | 15.40 | 19,755 | 304,227 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | D | 6.29 | 52,421 | 329,728 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | D | 0.14 | 65,849 | 9,219 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Sell | D | 34.50 | 7,840 | 270,480 | 0 | 7.8 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Sell | U | 34.50 | 91,697 | 3,163,547 | 0 | 91.7 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Sell | U | 34.50 | 70,561 | 2,434,355 | 0 | 70.6 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Option Exercise | D | 23.81 | 52,500 | 1,250,025 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Option Exercise | D | 23.72 | 71,250 | 1,690,050 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Option Exercise | D | 34.07 | 56,250 | 1,916,438 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Option Exercise | D | 19.63 | 70,000 | 1,374,100 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Option Exercise | D | 11.45 | 135,068 | 1,546,529 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Sell | D | 34.50 | 22,343 | 770,834 | 0 | 22.3 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Sell | U | 34.50 | 41,464 | 1,430,508 | 0 | 41.5 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Option Exercise | D | 17.11 | 15,398 | 263,460 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Option Exercise | D | 19.90 | 11,432 | 227,497 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Option Exercise | D | 32.79 | 7,500 | 245,925 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Option Exercise | D | 18.26 | 17,500 | 319,550 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Option Exercise | D | 15.40 | 19,755 | 304,227 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Sell | D | 34.50 | 7,840 | 270,480 | 0 | 7.8 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Sell | U | 34.50 | 69,894 | 2,411,343 | 0 | 69.9 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Sell | U | 34.50 | 65,192 | 2,249,124 | 0 | 65.2 K to 0 (-100.00 %) |
Oct 05 2020 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Option Exercise | M | 11.45 | 34,932 | 399,971 | 135,068 | |
Oct 05 2020 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Buy | M | 11.45 | 34,932 | 399,971 | 63,807 | 28.9 K to 63.8 K (+120.98 %) |
Oct 05 2020 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | M | 12.95 | 30,888 | 400,000 | 22,361 | |
Oct 05 2020 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Buy | M | 12.95 | 30,888 | 400,000 | 85,426 | 54.5 K to 85.4 K (+56.64 %) |
Oct 05 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | M | 19.44 | 5,200 | 101,088 | 264,800 | |
Oct 05 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Buy | M | 19.44 | 5,200 | 101,088 | 49,841 | 44.6 K to 49.8 K (+11.65 %) |
Oct 05 2020 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Option Exercise | M | 11.45 | 34,932 | 399,971 | 135,068 | |
Oct 05 2020 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Buy | M | 11.45 | 34,932 | 399,971 | 63,807 | 28.9 K to 63.8 K (+120.98 %) |
Oct 05 2020 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | M | 12.95 | 30,888 | 400,000 | 22,361 | |
Oct 05 2020 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Buy | M | 12.95 | 30,888 | 400,000 | 85,426 | 54.5 K to 85.4 K (+56.64 %) |
Oct 05 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | M | 19.44 | 5,200 | 101,088 | 264,800 | |
Oct 05 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Buy | M | 19.44 | 5,200 | 101,088 | 49,841 | 44.6 K to 49.8 K (+11.65 %) |
Sep 23 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | J | 0.00 | 91,697 | 0 | 91,697 | 0 to 91.7 K |
Sep 23 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Sell | J | 0.00 | 6,113,134 | 0 | 0 | 6.1 M to 0 (-100.00 %) |
Sep 23 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | J | 0.00 | 91,697 | 0 | 91,697 | 0 to 91.7 K |
Sep 23 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Sell | J | 0.00 | 6,113,134 | 0 | 0 | 6.1 M to 0 (-100.00 %) |
Sep 16 2020 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Payment of Exercise | F | 34.25 | 840 | 28,770 | 54,538 | 55.4 K to 54.5 K (-1.52 %) |
Sep 16 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Payment of Exercise | F | 34.25 | 840 | 28,770 | 26,595 | 27.4 K to 26.6 K (-3.06 %) |
Sep 16 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Payment of Exercise | F | 34.25 | 840 | 28,770 | 44,547 | 45.4 K to 44.5 K (-1.85 %) |
Sep 16 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Payment of Exercise | F | 34.25 | 1,642 | 56,239 | 117,034 | 118.7 K to 117 K (-1.38 %) |
Sep 16 2020 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Payment of Exercise | F | 34.25 | 840 | 28,770 | 28,875 | 29.7 K to 28.9 K (-2.83 %) |
Jun 26 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Payment of Exercise | F | 18.02 | 7,907 | 142,484 | 118,676 | 126.6 K to 118.7 K (-6.25 %) |
May 29 2020 | AIMT | Aimmune Therapeuti ... | Iwicki Mark T | Director | Option Exercise | A | 17.11 | 15,398 | 263,460 | 15,398 | |
May 29 2020 | AIMT | Aimmune Therapeuti ... | Iwicki Mark T | Director | Grant | A | 0.00 | 7,840 | 0 | 47,407 | 39.6 K to 47.4 K (+19.81 %) |
May 29 2020 | AIMT | Aimmune Therapeuti ... | Behar Gregory | Director | Option Exercise | A | 17.11 | 15,398 | 263,460 | 15,398 | |
May 29 2020 | AIMT | Aimmune Therapeuti ... | Behar Gregory | Director | Grant | A | 0.00 | 7,840 | 0 | 18,032 | 10.2 K to 18 K (+76.92 %) |
May 29 2020 | AIMT | Aimmune Therapeuti ... | HAUMANN BRETT K | Director | Option Exercise | A | 17.11 | 25,453 | 435,501 | 25,453 | |
May 29 2020 | AIMT | Aimmune Therapeuti ... | HAUMANN BRETT K | Director | Grant | A | 0.00 | 13,313 | 0 | 19,563 | 6.3 K to 19.6 K (+213.01 %) |
May 29 2020 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Option Exercise | A | 17.11 | 15,398 | 263,460 | 15,398 | |
May 29 2020 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Grant | A | 0.00 | 7,840 | 0 | 73,032 | 65.2 K to 73 K (+12.03 %) |
May 29 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 17.11 | 15,398 | 263,460 | 15,398 | |
May 29 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | S | 0.00 | 7,840 | 0 | 78,401 | 70.6 K to 78.4 K (+11.11 %) |
May 29 2020 | AIMT | Aimmune Therapeuti ... | MCDADE MARK | Director | Option Exercise | A | 17.11 | 15,398 | 263,460 | 15,398 | |
May 29 2020 | AIMT | Aimmune Therapeuti ... | MCDADE MARK | Director | Grant | A | 0.00 | 7,840 | 0 | 34,692 | 26.9 K to 34.7 K (+29.20 %) |
May 29 2020 | AIMT | Aimmune Therapeuti ... | Seltzer Stacey Denenberg | Director | Option Exercise | A | 17.11 | 15,398 | 263,460 | 15,398 | |
May 29 2020 | AIMT | Aimmune Therapeuti ... | Seltzer Stacey Denenberg | Director | Grant | A | 0.00 | 7,840 | 0 | 18,061 | 10.2 K to 18.1 K (+76.70 %) |
May 12 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Grant | A | 0.00 | 3,300 | 0 | 126,583 | 123.3 K to 126.6 K (+2.68 %) |
May 12 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Grant | A | 0.00 | 2,420 | 0 | 45,387 | 43 K to 45.4 K (+5.63 %) |
May 12 2020 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Grant | A | 0.00 | 2,420 | 0 | 55,378 | 53 K to 55.4 K (+4.57 %) |
May 12 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Grant | A | 0.00 | 2,420 | 0 | 27,435 | 25 K to 27.4 K (+9.67 %) |
May 12 2020 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Grant | A | 0.00 | 2,420 | 0 | 29,715 | 27.3 K to 29.7 K (+8.87 %) |
Apr 24 2020 | AIMT | Aimmune Therapeuti ... | Societe des Produits Nestle S. ... | 10% Owner | Buy | J | 161.10 | 525,634 | 84,679,637 | 525,634 | 0 to 525.6 K |
Apr 24 2020 | AIMT | Aimmune Therapeuti ... | Societe des Produits Nestle S. ... | 10% Owner | Buy | J | 16.11 | 12,727,113 | 205,033,790 | 12,727,113 | 0 to 12.7 M |
Apr 24 2020 | AIMT | Aimmune Therapeuti ... | Societe des Produits Nestle S. ... | 10% Owner | Buy | P | 319.68 | 525,634 | 168,032,049 | 525,634 | 0 to 525.6 K |
Apr 24 2020 | AIMT | Aimmune Therapeuti ... | Societe des Produits Nestle S. ... | 10% Owner | Buy | P | 31.97 | 1,000,000 | 31,970,000 | 12,727,113 | 11.7 M to 12.7 M (+8.53 %) |
Apr 24 2020 | AIMT | Aimmune Therapeuti ... | Nestle Health Science US Holdi ... | 10% Owner | Buy | P | 30.27 | 3,237,529 | 98,000,003 | 11,727,113 | 8.5 M to 11.7 M (+38.14 %) |
Apr 24 2020 | AIMT | Aimmune Therapeuti ... | Nestle Health Science US Holdi ... | 10% Owner | Buy | P | 32.00 | 937,500 | 30,000,000 | 8,489,584 | 7.6 M to 8.5 M (+12.41 %) |
Apr 24 2020 | AIMT | Aimmune Therapeuti ... | Nestle Health Science US Holdi ... | 10% Owner | Buy | P | 30.27 | 3,237,529 | 98,000,003 | 11,727,113 | 8.5 M to 11.7 M (+38.14 %) |
Apr 24 2020 | AIMT | Aimmune Therapeuti ... | Nestle Health Science US Holdi ... | 10% Owner | Buy | P | 32.00 | 937,500 | 30,000,000 | 8,489,584 | 7.6 M to 8.5 M (+12.41 %) |
Mar 19 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | P | 11.06 | 16,213 | 179,345 | 70,561 | 54.3 K to 70.6 K (+29.83 %) |
Mar 19 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | P | 11.50 | 8,787 | 101,051 | 54,348 | 45.6 K to 54.3 K (+19.29 %) |
Mar 19 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | P | 11.40 | 100,000 | 1,139,650 | 6,113,134 | 6 M to 6.1 M (+1.66 %) |
Mar 17 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Buy | P | 14.76 | 3,000 | 44,266 | 25,015 | 22 K to 25 K (+13.63 %) |
Mar 17 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Buy | P | 14.76 | 3,000 | 44,266 | 25,015 | 22 K to 25 K (+13.63 %) |
Mar 12 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Buy | P | 15.10 | 1,000 | 15,100 | 42,967 | 42 K to 43 K (+2.38 %) |
Mar 10 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Buy | P | 18.74 | 2,665 | 49,934 | 123,283 | 120.6 K to 123.3 K (+2.21 %) |
Mar 10 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Buy | P | 18.97 | 1,000 | 18,970 | 41,967 | 41 K to 42 K (+2.44 %) |
Mar 04 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Payment of Exercise | F | 23.81 | 1,982 | 47,191 | 40,967 | 42.9 K to 41 K (-4.61 %) |
Mar 04 2020 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Payment of Exercise | F | 23.81 | 1,872 | 44,572 | 27,295 | 29.2 K to 27.3 K (-6.42 %) |
Mar 04 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Payment of Exercise | F | 33.23 | 1,235 | 41,039 | 10,765 | 12 K to 10.8 K (-10.29 %) |
Mar 04 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Payment of Exercise | F | 23.81 | 3,081 | 73,359 | 120,618 | 123.7 K to 120.6 K (-2.49 %) |
Mar 04 2020 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Payment of Exercise | F | 23.81 | 3,960 | 94,288 | 52,958 | 56.9 K to 53 K (-6.96 %) |
Mar 03 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Option Exercise | A | 23.81 | 200,000 | 4,762,000 | 200,000 | |
Mar 03 2020 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Grant | A | 0.00 | 33,000 | 0 | 123,699 | 90.7 K to 123.7 K (+36.38 %) |
Mar 03 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | A | 23.81 | 56,250 | 1,339,313 | 56,250 | |
Mar 03 2020 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Grant | A | 0.00 | 9,375 | 0 | 42,949 | 33.6 K to 42.9 K (+27.92 %) |